Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: J Pharmacol Exp Ther. 2008 May 7;326(2):363–368. doi: 10.1124/jpet.108.139543

Table 4.

Toxicology studies of orpiment, realgar and arsenolite/arsenic trioxide

Arsenicals Acute Toxicity Chronic Toxicity Comments
Orpiment N/A Negative in micronucleus assay High As levels in blood
Negative in lung tumor formation
Reaglar N/A Cutaneous manifestations Adverse effects
Mild GI discomfort in chemotherapy Tolerable
Prolonged QT, dose-dependent Tolerable
Fatty liver, but no liver fibrosis Long-term exposure
Arsenic trioxide Sudden death, poisoning Cardiac effects and GI effects Chelation effective
Skin and GI effects Tolerable
No secondary cancer reports